Recent Posts

Pages: 1 [2] 3 4 5 6 ... 10
11
That's Ohio for you. Ohio be like:
12
Although voters overwhelmingly chose to legalize recreational marijuana in 2023, one of the most powerful leaders in the state plans to dramatically change what Ohioans selected. So far, the policy has been safeguarded, but it likely won’t be in 2025.

Nearly $200 million of adult-use cannabis has been sold in the four months that sales have been allowed, according to the Department of Cannabis Control.

This is all thanks to the passage of Issue 2 in 2023, which allowed adults 21 years of age and older to smoke, vape and ingest weed. Individual Ohioans are able to grow up to six plants with up to 12 per household.

But dispensaries and users are worried because Ohio Senate President Matt Huffman, R-Lima, wants to change the policy.

“There were some fundamental flaws in the initiative that was introduced and passed by the voters — which you usually have when there’s not a vetting from all sides,” Huffman said last Wednesday. “The bill that the Senate passed last December addresses many of those things.”


In December of 2023, the Senate passed a bill to restrict marijuana. If signed into law, it would decrease the THC content and raise the cost. Among dozens of other restrictions and changes to what the voters chose, it would ban the vast majority of vapes. It would also limit home-growing marijuana from 12 plants to six.

“The amount of home growth that’s happening, of course, is far beyond the use for one to two people who may be growing it in their home… The only reason that someone would be growing that much marijuana is to resell it,” Huffman added, later saying that someone growing 12 plants would likely be participating in the “illicit market.”

House leaders, specifically marijuana enthusiast state Rep. Jamie Callender, R-Concord, have been adamant about listening to Ohioans, blocking Huffman’s proposal.

Sales have already been in motion since August, so he said changing the law now would be harmful and confusing.

“One of the things that this day helps is to move one step forward — to show that the world doesn’t fall apart, the sky isn’t falling,” Callender told me on the first day of sales.

House Speaker Jason Stephens, R-Kitts Hill, Huffman’s rival, isn’t impressed with the president’s recent comments.

“As we’ve said, this is the People’s House, and we will continue to respect the will of the voters,” Stephens said in response.

But in January, Huffman is set to become the speaker of the House, so he has a better chance at changing the law.

In the meantime, both chambers agree to revise the policy on Delta 8, a hemp product. Right now, it’s legal for anyone to buy this low-level marijuana at convenience stores.

“I think it’s very appropriate to look at age limits, similar to other products, whether it’s tobacco or alcohol,” Stephens said.

However, a bill going through the Senate would completely ban it. But it seems the bill sponsor would consider an amendment to restrict and not totally prohibit it.

“We need to get that regulated,” Huffman said.

House leaders have continuously said they will fight against “anti-democratic” policies regarding marijuana. Senate leaders have said that they aren’t ignoring the will of the people because, they claim, voters didn’t really know everything that they were voting on.


Source: https://ohiocapitaljournal.com/2024/12/09/ohio-gop-again-proposes-restricting-marijuana-and-making-it-more-expensive/
13
Nearly $13 billion in U.S. taxpayer money has gone to fund worldwide counternarcotics activities since 2015, often coming at the expense of efforts to end global poverty while at the same time contributing to international human rights violations and environmental harms. That’s according to a new report issued on Wednesday by two organizations critical of the war on drugs.

The 47-page document, jointly published by the Drug Policy Alliance (DPA) and Harm Reduction International (HRI), consists of what it describes as a “follow-the-money data analysis” that looks at anti-drug spending allocations across various government departments as well as case studies from Colombia, Mexico and the Philippines.

Authors wrote that the analysis “demonstrates how U.S. assistance has supported and expanded destructive and deadly anti-drug responses in low- and middle-income countries around the world.”

The $13 billion figure, the report says, “is more taxpayer money than the U.S. government spent over that decade on primary education or water supply and sanitation in low- and middle-income countries” and also greater than U.S. foreign aid over the same period “for all of Southern Africa or Central America.”

It’s also “about 300 times the total amount of U.S. foreign aid over that decade for women’s rights organizations in low-and middle-income countries around the whole world,” it adds.

DPA said in an email about the report that the topic is “especially timely as President-elect Trump and members of his administration threaten to ramp up the global war on drugs and increase punitive responses to international drug markets.”

For fiscal year 2025 alone, the report says, President Joe Biden “requested $1 billion for international ‘counternarcotics’ activities,” about half of which ($480 million) would be allocated to the Drug Enforcement Administration (DEA), while about $350 million would have gone to the State Department.

“The role of the United States in exporting the destructive war on drugs to other countries is unparalleled,” DPA and HRI said in an executive summary of the findings. ”

DRUG ENFORCEMENT AGENCY’S GLOBAL INFRASTRUCTURE
Harm Reduction International & Drug Policy Alliance

“Since 1971, the U.S. has spent more than a trillion dollars on the war on drugs, prioritizing law enforcement responses and fueling mass incarceration within its borders,” it says. “It has also played a leading role in pushing and funding punitive responses to drugs internationally.”

In terms of money earmarked for global aid efforts, the report says, a growing amount of drug war funding has “even come from the same U.S. official development assistance budgets that are supposed to help end global poverty and support other sustainable development goals.”

The U.S. contributed “more than half of the about $1 billion in official development assistance” since 2013 that’s been earmarked for counter-drug efforts, it adds.

A separate HRI report published about a year ago found that from 2012 to 2021, 30 donor countries spent $974 million in international aid funding on drug control. That included $70 million spent in countries where drug charges can carry the death penalty.

As in the new report, the earlier analysis found that the U.S. led all nations in terms of funding from global aid, providing about $550 million. Next came the European Union ($282 million) followed by Japan ($78 million), and the United Kingdom ($22 million).

U.S. DRUG CONTROL INTERNATIONAL FUNDING (FY 2015 - 2025, IN MILLIONS)
Harm Reduction International & Drug Policy Alliance

In terms of the harms of the drug war, the new report points to “human rights abuses, rising HIV rates, aerial fumigation with toxic chemicals, and militarized responses in various regions.”

In Colombia, for example, aerial fumigation led not only to crop destruction but also displaced and caused health harms in resident communities.

In the Philippines, which has seen vigilante killings of drug users and distributors, millions of USAID money went to fund what the report calls “forced rehabilitation” of drug consumers. Meanwhile, it says, HIV rates have risen sharply, with the country seeing the highest increases in the Asia-Pacific region from 2010 to 2021.

“An estimated 29% of people who inject drugs in the Philippines are living with HIV,” the report says, but many harm-reduction services are unavailable: “Sterile injecting equipment is considered illegal by the Philippines Dangerous Drugs Board and is thus hard to access.”

In Mexico, meanwhile, the report says tracking U.S. drug war spending is difficult. Despite the country being one of the largest targets of anti-drug efforts, sweeping portions of publicly available information on counternarcotics spending is redacted.


Funding counternarcotics efforts has also contributed to a more armed and violent drug war, the report says, calling increasing militarization a “defining feature of Mexico’s war on drugs that has been supported by the U.S.” Encouraged by administrations here, successive presidents in Mexico have stepped up the military’s role in policing drug activities as well as handling other civil tasks.

U.S. support for Mexico’s drug war “has had devastating impacts on communities,” DPA and HRI concluded, “contributing to militarization of law enforcement, increased violence, repression, and an erosion of democratic institutions.”

The two organizations end the report with a list of recommendations for the federal government, U.S. civil society and journalists as well as taxpayers in general.

Regarding the government, the report calls on officials to “divest from punitive and prohibitionist drug control regimes” and cease using foreign aid “as ‘leverage’ and as a means to pressure low- and middle-income countries to adopt or maintain punitive drug responses.”

It also urges investment research as well as funding evidence-based treatment and human rights-focused harm reduction efforts—including an end to the ban on using federal funds to purchase syringes.

The report also says increased transparency is needed, advising not only the government to be more open but also journalists and civil society organizations to demand more accountability in how taxpayer funds are spent.

It says news outlets should “conduct further, in-depth-investigations into how U.S. money has been spent on drug control internationally, including how it was justified, any results claimed, and any direct or indirect impacts that may have undermined other goals or aid rules.”

Of taxpayers themselves, the report says individuals should “demand integrity and transparency in the government’s international spending, including that from limited aid budgets” and demand that more public money “flows to evidence-based and health- and human rights-centered measures, not for punitive drug control abroad.”

Another group, the International Coalition on Drug Policy Reform and Environmental Justice, published a report last year looking at environmental harms of the drug war, warning that efforts to address climate change must be paired with drug policy reform.

As policymakers, governments, NGOs and activists work to craft urgent responses to protect tropical forests, which are some of the largest carbon sinks on the planet, that report said, “their efforts will fail as long as those committed to environmental protection neglect to recognize, and grapple with, the elephant in the room”—namely “the global system of criminalized drug prohibition.”

United Nations (UN) bodies have also urged a shift away from punitive drug policies, which they link to increases in wider harms.

A statement from UN special rapporteurs, experts and working groups earlier this year said that the drug war “has resulted in a range of serious human rights violations, as documented by a number of UN human rights experts over the years.”

“We collectively urge Member States and all UN entities to put evidence and communities at the centre of drug policies, by shifting from punishment towards support, and invest in the full array of evidence-based health interventions for people who use drugs, ranging from prevention to harm reduction, treatment and aftercare, emphasizing the need for a voluntary basis and in full respect of human rights norms and standards,” the statement said.

The UN experts’ statement also highlighted a number of other UN agency reports, positions, resolutions as well as actions in favor of prioritizing prevention and harm reduction over punishment.

It pointed, for example, to what it called a “landmark report” published by the UN special rapporteur on human rights that encouraged nations to abandon the criminal war on drugs and instead adopt harm-reduction policies—such as decriminalization, supervised consumption sites, drug checking and widespread availability of overdose reversal drugs like naloxone—while also moving toward “alternative regulatory approaches” for currently controlled substances.

That report noted that “over-criminalisation, stigmatisation and discrimination linked to drug use represent structural barriers leading to poorer health outcomes.”

Advocacy to reform the global war on drugs comes as international bodies and national governments across the world consider adjusting their approaches to drug control and regulation.

Late last year, for example, 19 Latin American and Caribbean nations issued a joint statement acknowledging the need to rethink the global war on drugs and instead focus on “life, peace and development” within the region.

A year ago, a separate UN special rapporteurs report said that “the ‘war on drugs’ may be understood to a significant extent as a war on people.”

“Its impact has been greatest on those who live in poverty,” they said, “and it frequently overlaps with discrimination directed at marginalised groups, minorities and Indigenous Peoples.”

In 2019, the UN Chief Executives Board (CEB), which represents 31 UN agencies including the UN Office on Drugs and Crime (UNODC), adopted a position stipulating that member states should pursue science-based, health-oriented drug policies—namely decriminalization.

https://www.marijuanamoment.net/u-s-taxpayers-spent-almost-13b-to-fund-global-war-on-drugs-in-the-past-decade-report-shows/

14
DEA to Hold Hearing on the Rescheduling of Marijuana
MEDIA ADVISORY
DEA Headquarters Division - Public Information Office
WASHINGTON – Formal hearing proceedings regarding the proposed rescheduling of marijuana will begin on December 2, 2024 at 9:30 A.M. ET in the North Courtroom at DEA Headquarters located at 700 Army Navy Drive, Arlington, VA. This preliminary hearing will serve as a procedural day to address legal and logistical issues and discuss future dates for the evidentiary hearing on the merits.  No witness testimony will be offered or received at this time. 

In-person attendance is limited to designated participants and credentialed members of the media who have received confirmation of their in-person attendance.

WHAT:    Commencement of formal hearing proceedings regarding the proposed rescheduling of Marijuana

WHO:    Open to designated participants and designated credentialed members of the media.
           
WHEN:        December 2, 2024 | 9:30 a.m. to 5 p.m.

WHERE:     DEA Headquarters | 700 Army Navy Drive, Arlington, Va. 22202 | North Courtroom


FOR MEMBERS OF THE PUBLIC: Members of the public will have access to the court sessions virtually at www.DEA.gov/live

FOR NEWS MEDIA: News media wishing to attend in person must RSVP to DEAPress@dea.gov by 10 a.m. on November 29, 2024.  Due to limited capacity, RSVPs will be accepted on a first come, first served basis.

Designated members of the media should arrive no later than 9:00 a.m. on December 2 and follow all security screening procedures. Media credentials are required to be visible while inside DEA Headquarters. Video and audio recordings are not permitted at any time inside the courtroom.
   
Background:
On May 21, 2024, the Department of Justice proposed to transfer marijuana from schedule I of the Controlled Substances Act to schedule III of the CSA, consistent with the view of the Department of Health and Human Services that marijuana has a currently accepted medical use as well as HHS's views about marijuana's abuse potential and level of physical or psychological dependence. The CSA requires that such actions be made through formal rulemaking on the record after opportunity for a hearing. If the transfer to schedule III is finalized, the regulatory controls applicable to schedule III controlled substances would apply, as appropriate, along with existing marijuana-specific requirements and any additional controls that might be implemented, including those that might be implemented to meet U.S. treaty obligations. If marijuana is transferred into schedule III, the manufacture, distribution, dispensing, and possession of marijuana would remain subject to the applicable criminal prohibitions of the CSA. Any drugs containing a substance within the CSA's definition of “marijuana” would also remain subject to the applicable prohibitions in the Federal Food, Drug, and Cosmetic Act. For more information, visit www.DEA.gov.

Source: https://www.dea.gov/stories/2024/2024-11/2024-11-26/dea-hold-hearing-rescheduling-marijuana
15
Cannabis General / Re: Ohio Lawmakers Want to Make Cannabis Illegal Again
« Last post by orthene on November 27, 2024, 10:29:38 AM »
Ohio's lawmakers are tone deaf, and the state is always going to be the last, or one of the last, to put a foot forward. Always waiting on all the other states before putting a toe in the water.
16
Cannabis General / Re: Gelato 47 AKA Mochi
« Last post by BurnMan on November 25, 2024, 09:41:37 PM »
Still have 16 sq ft on the right. I will be putting up another row of lights above the two empty flood trays.

I have about 20 Spider Farmer SF1000D's.
17
Cannabis General / Ohio Lawmakers Want to Make Cannabis Illegal Again
« Last post by BurnMan on November 25, 2024, 09:40:04 PM »
Hello, Ohio cannabis community,


The newly legalized recreational marijuana program in Ohio is under threat. Matt Huffman, recently chosen as the next Speaker of the Ohio House, has made it clear that reversing cannabis legalization is a top priority. Huffman believes that voters were misinformed when they approved Issue 2 in November 2023, and he is working to make sweeping changes to the law—or possibly undo it altogether.


What’s Happening?

Huffman, a hardline conservative, has proposed several changes to Ohio’s recreational marijuana law, including:


Drastically limiting THC levels in cannabis products.

Modifying key provisions to impose stricter regulations.

Revisiting the law altogether to potentially make recreational cannabis illegal again.

Under the current law, adults 21 and older can possess up to 2.5 ounces of marijuana and 15 grams of concentrates. Since sales began on August 6, 2024, the program has generated over $160 million in revenue and created numerous jobs. Despite these successes, Huffman argues that voters didn’t fully understand what they were approving.


Not Everyone Agrees

Huffman’s plans have sparked resistance, even within his own party. State Representative Ron Ferguson, a fellow Republican, has vowed to uphold the will of the voters. “Marijuana policy, for the most part, has been decided by the voters,” Ferguson said. “I support what they decided.”


This internal division in the Republican Party could shape the future of recreational cannabis in Ohio.


Why This Matters

Ohioans voted for legal cannabis, and any attempt to undo this decision undermines the democratic process. Beyond respecting the voters’ will, the cannabis program has brought significant economic benefits to the state. Rolling back legalization could stall economic progress, harm small businesses, and send the wrong message to Ohio’s voters.

Source: https://www.ohiocannabislive.com/post/ohio-lawmakers-want-to-make-cannabis-illegal-again

18
Cannabis General / Kentucky doctors can begin prescribing medical cannabis Dec. 1
« Last post by BurnMan on November 25, 2024, 09:37:44 PM »
Starting Dec. 1, Kentuckians with a range of chronic illnesses can begin visiting their doctor to be approved for medical marijuana. Patients wanting access must have received written certification from their physician.
Patients suffering a wide range of chronic conditions including cancer, Parkinson’s Disease, arthritis, and PTSD must first receive written certification from their physician to access medical cannabis.

“To date, 154 doctors and APRNS have become authorized medical cannabis practitioners and that number is growing steadily each week," Gov. Andy Beshear said during a news conference Thursday.

Also on Dec. 1, the state will launch an online directory of medical cannabis practitioners on the Office of Medical Cannabis website. The portal featuring approved physicians will be searchable by location and specialty, and will be updated as more health care providers become certified to prescribe medical cannabis.

Medical cannabis will become legal in Kentucky on Jan. 1, but patients won’t be able to access the drug that quickly. Spring or summer is a more likely start time. Availability will also depend on how soon dispensaries can be inspected before starting operations.

On Monday, Nov. 25, the state will hold the first of two random drawings for dispensary licenses. There are 48 of those licenses available across the state's 11 licensing regions, which is a small number compared to the list of applicants.

“Over 4,000 applicants applied for a dispensary license," Beshear said. "Dispensary applications represent over 80% of the total applications we received.”

Monday's lottery is for nine of the 11 regions: Northeast, South Central, Cumberland, Mountain, Pennyrile, West Kentucky, Lincoln Trail, Northern Kentucky, and Green River.

The final dispensary license drawing will be held on Dec.16 for the Kentuckiana and Bluegrass regions that include Jefferson and Fayette counties.

All of the lotteries are being held by the Kentucky Lottery Corporation and lived streamed on the Office of Medical Cannabis’ YouTube Channel​.

So far, 29 licenses have been approved for cultivators, processors, and testing labs.

Source https://www.lpm.org/news/2024-11-22/kentucky-doctors-can-begin-prescribing-medical-cannabis-dec-1

19
Cannabis General / Re: Gelato 47 AKA Mochi
« Last post by orthene on November 25, 2024, 10:07:18 AM »
Plants look nice and healthy. You made the most of the space you have there.
20
Cannabis General / Re: Gelato 47 AKA Mochi
« Last post by 1954 on November 24, 2024, 01:42:38 PM »
great looking grow room. looking forward to seeing progress.
Pages: 1 [2] 3 4 5 6 ... 10
SimplePortal 2.3.7 © 2008-2025, SimplePortal